HIV Drug Patents in China
Data from HIV Chinese Patent Landscape Report.
Identifying and analysing the relevant patents for a medicine can be a difficult and time consuming exercise. Without the correct information, advocacy and procurement decisions can be ineffective.
HIV Drug Patents in China
Data from HIV Chinese Patent Landscape Report.
Hepatitis C
Data from Patent Landscape Report for Pegylated Interferon Alfa 2A & 2B
Tuberculosis Patent Landscapes
Bedaquiline (TMC 207), Delamanid (OPC 67683), SQ-109, AZD 5847, PNU-100480 and PA 824
Patent Landscape Report For Pegylated Interferon Alfa 2A & 2B
HIV Drug Patents in China – A Patent Landscape
This report focuses on the HIV drug patent landscape in China. The patents included this landscape include key ARV patents that are likely to have a bearing on procurement decisions in China.
Learn more about how you can help build a more equitable system for all